Innovent Biologics Inc. revenue breakdown overview

Innovent Biologics Inc. revenue for the last year amounted to 874.12 M USD, the most of which — 877.99 M USD — came from its highest performing source at the moment, Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development, the year earlier bringing 678.26 M USD. The greatest contribution to the revenue figure was made by China — last year it brought Innovent Biologics Inc. 813.94 M USD, and the year before that — 615.17 M USD.